VLA 0.00% $1.75 viralytics limited

big pharma take over, page-4

  1. 1,102 Posts.
    lightbulb Created with Sketch. 5
    Would a sale of Cavatak be restricted to melanoma treatment only . What about the other cancers where trials have been carried out and are proposed for the future . As far as I know T-Vec is only being trialled for melanoma . Surely with its wide range of possibilities Cavatak is worth a lot more than T-Vec . Could Cavatak be sold to a number of pharmas for different cancer treatments .
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.